|
TTC9C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.223600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.830400E-04 |
| Normal-vs-Stage2 |
6.910000E-01 |
| Normal-vs-Stage3 |
2.403800E-01 |
| Normal-vs-Stage4 |
7.307600E-01 |
| Stage1-vs-Stage2 |
9.482400E-02 |
| Stage1-vs-Stage3 |
9.839500E-03 |
| Stage1-vs-Stage4 |
7.742000E-02 |
| Stage2-vs-Stage3 |
6.226400E-01 |
| Stage2-vs-Stage4 |
9.810600E-01 |
| Stage3-vs-Stage4 |
7.026600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.196260E-02 |
| Normal-vs-AfricanAmerican |
9.316400E-01 |
| Normal-vs-Asian |
8.372400E-01 |
| Caucasian-vs-AfricanAmerican |
1.054000E-01 |
| Caucasian-vs-Asian |
3.900400E-01 |
| AfricanAmerican-vs-Asian |
8.255200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.760070E-04 |
| Normal-vs-Female |
5.304000E-02 |
| Male-vs-Female |
1.86689999999157E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.562800E-01 |
| Normal-vs-Extreme_Weight |
3.91339999999962E-05 |
| Normal-vs-Obese |
7.990800E-01 |
| Normal-vs-Extreme_Obese |
4.780000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.392100E-02 |
| Normal_Weight-vs-Obese |
8.260800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.597820E-01 |
| Extreme_Weight-vs-Obese |
4.581600E-04 |
| Extreme_Weight-vs-Extreme_Obese |
7.151400E-01 |
| Obese-vs-Extreme_Obese |
5.084400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.146800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.331200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.404600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.352200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.348100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.704270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.417900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.127240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.078000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.499200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.08429999995585E-06 |
| Normal-VS-Type2 PRCC |
9.108200E-01 |
| Normal-VS-KIRP CIMP |
8.248300E-04 |
| Normal-VS-Unclassified PRCC |
8.156600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.792170E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.34899935245426E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
1.079610E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.67230000000563E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
7.738800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.594200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.543000E-01 |
| Normal-vs-N1 |
3.697800E-02 |
| Normal-vs-N2 |
9.366000E-01 |
| N0-vs-N1 |
1.282350E-02 |
| N0-vs-N2 |
8.175600E-01 |
| N1-vs-N2 |
3.549000E-01 |
|
|
